Gary Bridger is Director at X4 Pharmaceuticals, Inc (XFOR). They have made 1 open-market trade across 1 company since 2014, most recently 2025-06-09.
CIK 0001600049
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $2.5M since 2014, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ALDR | BUY | 2014-05-13 | 2014-05-15 | $10.00 | $2.5M | -19.9% | -2.2% | -2.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.